Investigational Pentavalent Botulinum Toxoid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational Pentavalent Botulinum Toxoid, covering 2017-02-09 to 2017-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid [Phase 2]